Skip to main content
Retour
Watch Compare

Aclarion, Inc.

Qualité des données : 100%
Également cotée sous ACONW Nasdaq
ACON
Nasdaq Services Health Services
3,53 €
▼ 0,04 € (-1,12%)
Cap. Boursière: 8,06 M
Prix
3,53 €
Cap. Boursière
8,06 M
Fourchette du Jour
3,49 € — 3,94 €
Fourchette 52 Semaines
2,34 € — 12,03 €
Volume
479 579
Ouverture 3,71 €
Moyenne 50J / 200J
3,05 €
15,64% above
Moyenne 50J / 200J
5,99 €
41,03% below

Quick Summary

Points Clés

Negative free cash flow of -7,19 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)65,62%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-54,20%
En dessous de la moyenne du secteur (-15,95%)
ROIC-41,75%
Net Margin-9551,87%
Op. Margin-9312,55%

Sécurité

Debt / Equity
N/A
Current Ratio17,01
Interest CoverageN/A

Valorisation

PE (TTM)
-1,11
Au-dessus de la moyenne du secteur (-1,17)
P/B Ratio0,64
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (502 pairs)
Métrique Action Médiane du Secteur
P/E -1,1 -1,2
P/B 0,6 1,4
ROE % -54,2 -16,0
Net Margin % -9551,9 -19,4
Rev Growth 5Y % — 4,0
D/E — 0,4

All Fundamental Metrics
Growth
Revenue Growth (1Y) 65,62% Revenue Growth (3Y) 0,22%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 75 730,0 Net Income (TTM) -7,23 M
ROE -54,20% ROA -51,75%
Gross Margin 9,02% Operating Margin -9312,55%
Net Margin -9551,87% Free Cash Flow (TTM) -7,19 M
ROIC -41,75% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 17,01
Interest Coverage N/A Asset Turnover 0,01
Working Capital 11,20 M Tangible Book Value 11,22 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,11 Forward P/E N/A
P/B Ratio 0,64 P/S Ratio 106,39
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -89,19%
Market Cap 8,06 M Enterprise Value -3,28 M
Per Share
EPS (Diluted TTM) -13,61 Revenue / Share 0,03
FCF / Share -3,15 OCF / Share -3,14
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 28,43% FCF Conversion 99,34%
SBC-Adj. FCF -7,36 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 75 730,0 45 724,0 75 404,0 60 444,0
Net Income -7,23 M -6,99 M -4,91 M -7,61 M
EPS (Diluted) -13,61 -7480,00 -8,82 -1,31
Gross Profit 6 828,0 -38 934,0 -324,0 -4 854,0
Operating Income -7,05 M -5,51 M -4,88 M -6,10 M
EBITDA — — — —
R&D Expenses 1,03 M 888 766,0 873 336,0 1,09 M
SG&A Expenses — — — —
D&A 227 406,0 193 139,0 162 670,0 193 621,0
Interest Expense — 64 084,0 608 288,0 1,51 M
Income Tax 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 13,67 M 2,12 M 2,46 M 3,21 M
Total Liabilities 837 287,0 — — —
Shareholders' Equity 12,84 M 970 057,0 -727 995,0 1,79 M
Total Debt — — — —
Cash & Equivalents 12,02 M 453 661,0 1,02 M 1,47 M
Current Assets 12,40 M 824 279,0 1,29 M 1,99 M
Current Liabilities 837 287,0 1,15 M 3,19 M 1,42 M